Dr. Maureen McEvoy explains breast cancer surgery options, reconstruction, recovery and how to close gaps in access to care.
|Articles|September 18, 2014
- Fall 2014
- Volume 13
- Issue 3
TriageCancer.org
Author(s)Jon Garinn
Triage Cancer is a nonprofit organization that provides education and resources about an array of survivorship issues.
Advertisement
Started by two cancer rights attorneys, Triage Cancer is a nonprofit organization that provides education and resources about an array of survivorship issues, including nutrition, fertility, employment, legal matters, financial concerns, insurance, sexuality, pain management, advocacy and more. Through the organization’s website, users can access a speakers bureau of experts, an educational blog, previous seminars and webinars, tools and resources, as well as support for educational event planning. To learn more, visit
Articles in this issue
about 12 years ago
Low-Risk Cancers: Can We Ignore Them?about 12 years ago
Meeting Dr. Brodieabout 12 years ago
Managing Arthralgiaabout 12 years ago
Pipelineabout 12 years ago
Skin Cancer's Risk is Cumulativeabout 12 years ago
Thyroid Cancer Survivors' Conferenceabout 12 years ago
Living with Lymphedemaabout 12 years ago
The DCIS Dilemmaabout 12 years ago
Personalizing Cancer Care with Precision Medicineabout 12 years ago
Preparing for a Cancer-Related EmergencyAdvertisement
Related to this article
For Blood Cancer Awareness Month, Dr. Guenther Koehne shares why immunotherapy is making this a promising time for people with blood cancers.
A cancer survivor reflects on losing her hair during chemotherapy, the emotional impact of hair loss and what growing it back taught her about healing, identity and life.
After a lung cancer diagnosis, one Bronx writer reflects on faith, survivorship and learning that healing isn't a finish line, but a daily journey.
Dr. David DiBardino explains how intratumoral therapy is being studied to deliver treatment directly into tumors and potentially enhance radiation in patients with locally advanced non-small cell lung cancer.
After lymphoma returned in his brain, one cancer survivor reflects on hospice, mortality, family, jealousy and gratitude for the life he was able to live.
See how FDA-approved lymphoma treatments have changed over 5 years — what's new, who it's helped, and what's still to come.
Kazia Therapeutics CEO Dr. John Friend discussed how paxalisib is being studied in HR-positive, HER2-negative breast cancer, why researchers are focusing on treatment resistance and what the ongoing clinical trial could show for patients.
Advertisement
Advertisement